9-(Tetrahydro-2H-pyran-2-yl)-9H-purin-6-amine, 95.0%, 100mg

(3-FLUORO-2-METHOXYPYRIDIN-4-YL)BORONIC ACID, 95.0%, 5g

Tetrapropylammonium Hydroxide (10% in Water)100mL

2-N-NONYL-1,3-DIOXOLANE, 97.0%, 1g

3,6-Bis(5-bromothiophen-2-yl)-2,5-bis(2-octyldodecyl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 95%, 100mg

Oxaliplatin100mg

tert-Butyl acrylate (stabilised with MEHQ), 98.0%, 500ml

2,2-Di(2-tetrahydrofuryl)propane>96.0%(GC)500mL

DL-Cystine, min. 98.5%, 1 g, glass packaging

3-Methyl-4-bromopyrazole, 95.0%, 100g

5,6,7,8-Tetrahydroimidazo[1,2-a]pyridine-3-carboxylic acid, 98%, 250mg

2-(3-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 1g

4-Aminopyridine-2,6-dicarboxylic acid, 95.0%, 250mg